| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis B virus | 13 | 2019 | 882 | 3.37 | Why? |
| Hepatitis B | 9 | 2019 | 888 | 2.53 | Why? |
| Hepatitis B, Chronic | 8 | 2019 | 616 | 2.08 | Why? |
| Hepatocytes | 7 | 2019 | 549 | 0.95 | Why? |
| Hepatitis B Vaccines | 2 | 2018 | 245 | 0.72 | Why? |
| Hepatitis C | 2 | 2019 | 1514 | 0.64 | Why? |
| Lipase | 1 | 2018 | 153 | 0.63 | Why? |
| Immunotherapy | 2 | 2018 | 2421 | 0.54 | Why? |
| Hepatitis E virus | 1 | 2017 | 306 | 0.51 | Why? |
| Hepacivirus | 2 | 2019 | 1509 | 0.44 | Why? |
| Liver Neoplasms | 4 | 2017 | 1666 | 0.44 | Why? |
| Carcinoma, Hepatocellular | 3 | 2017 | 1222 | 0.44 | Why? |
| RNA | 1 | 2017 | 1278 | 0.39 | Why? |
| Hepatitis C, Chronic | 1 | 2019 | 973 | 0.39 | Why? |
| Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.38 | Why? |
| Hepatitis Delta Virus | 2 | 2019 | 54 | 0.37 | Why? |
| Kupffer Cells | 2 | 2018 | 34 | 0.36 | Why? |
| Organic Anion Transporters, Sodium-Dependent | 2 | 2017 | 26 | 0.35 | Why? |
| Adaptive Immunity | 2 | 2021 | 2585 | 0.34 | Why? |
| HLA-B Antigens | 2 | 2019 | 166 | 0.34 | Why? |
| Symporters | 2 | 2017 | 80 | 0.33 | Why? |
| Hepatitis B Surface Antigens | 3 | 2017 | 305 | 0.33 | Why? |
| Liver Cirrhosis | 2 | 2017 | 1810 | 0.32 | Why? |
| Interferons | 1 | 2019 | 2885 | 0.32 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.31 | Why? |
| Family | 1 | 2020 | 2909 | 0.31 | Why? |
| Interferon Type I | 1 | 2019 | 2789 | 0.30 | Why? |
| DNA, Circular | 2 | 2019 | 26 | 0.24 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.22 | Why? |
| DNA, Viral | 4 | 2019 | 2521 | 0.21 | Why? |
| Gliosis | 1 | 2019 | 16 | 0.21 | Why? |
| Chemokine CCL19 | 1 | 2019 | 22 | 0.21 | Why? |
| Diagnostic Equipment | 1 | 2020 | 41 | 0.21 | Why? |
| CD8-Positive T-Lymphocytes | 4 | 2019 | 5837 | 0.21 | Why? |
| Interferon-alpha | 2 | 2019 | 1442 | 0.20 | Why? |
| Hepatitis D, Chronic | 1 | 2019 | 16 | 0.20 | Why? |
| Primary Cell Culture | 2 | 2018 | 501 | 0.20 | Why? |
| Central Nervous System Neoplasms | 1 | 2019 | 88 | 0.19 | Why? |
| Hepatitis delta Antigens | 1 | 2018 | 6 | 0.19 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.19 | Why? |
| Hepatic Stellate Cells | 1 | 2018 | 35 | 0.19 | Why? |
| Immunologic Surveillance | 1 | 2019 | 69 | 0.19 | Why? |
| Mucosal-Associated Invariant T Cells | 1 | 2021 | 170 | 0.19 | Why? |
| Infarction, Middle Cerebral Artery | 1 | 2021 | 203 | 0.18 | Why? |
| Hepatitis D | 1 | 2018 | 48 | 0.18 | Why? |
| N-Glycosyl Hydrolases | 1 | 2017 | 19 | 0.18 | Why? |
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 12 | 0.18 | Why? |
| Cell Polarity | 1 | 2018 | 85 | 0.18 | Why? |
| Receptors, Pattern Recognition | 1 | 2018 | 128 | 0.17 | Why? |
| DNA Repair | 1 | 2017 | 114 | 0.17 | Why? |
| Cytidine Deaminase | 1 | 2017 | 109 | 0.17 | Why? |
| HLA-A Antigens | 1 | 2019 | 196 | 0.17 | Why? |
| Cell Line, Tumor | 4 | 2019 | 3608 | 0.17 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.16 | Why? |
| Hepatitis, Viral, Animal | 1 | 2018 | 274 | 0.16 | Why? |
| Apolipoproteins E | 1 | 2018 | 170 | 0.16 | Why? |
| Immune Tolerance | 2 | 2019 | 608 | 0.16 | Why? |
| Lipoproteins | 1 | 2018 | 240 | 0.16 | Why? |
| Mutant Proteins | 1 | 2017 | 328 | 0.15 | Why? |
| Activation, Metabolic | 1 | 2014 | 6 | 0.15 | Why? |
| Macaca | 1 | 2017 | 388 | 0.15 | Why? |
| Cells, Cultured | 4 | 2019 | 5835 | 0.15 | Why? |
| Germany | 5 | 2021 | 9196 | 0.14 | Why? |
| Liver | 3 | 2018 | 4007 | 0.14 | Why? |
| Cholangiocarcinoma | 1 | 2017 | 186 | 0.14 | Why? |
| MAP Kinase Signaling System | 1 | 2017 | 360 | 0.14 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.14 | Why? |
| Bile Duct Neoplasms | 1 | 2017 | 172 | 0.14 | Why? |
| Lymphoma | 1 | 2019 | 522 | 0.13 | Why? |
| Superinfection | 1 | 2019 | 459 | 0.13 | Why? |
| Models, Animal | 1 | 2017 | 788 | 0.13 | Why? |
| Lymphocyte Activation | 2 | 2021 | 2742 | 0.13 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.13 | Why? |
| Interferon-beta | 1 | 2019 | 979 | 0.12 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.12 | Why? |
| Leupeptins | 1 | 2012 | 49 | 0.12 | Why? |
| Calpain | 1 | 2012 | 39 | 0.12 | Why? |
| Infectious Disease Incubation Period | 1 | 2020 | 1033 | 0.12 | Why? |
| Hepatitis E | 1 | 2017 | 319 | 0.12 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.11 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
| Fatty Liver | 1 | 2014 | 299 | 0.10 | Why? |
| Humans | 36 | 2021 | 930598 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 2 | 2019 | 2262 | 0.10 | Why? |
| Virus Replication | 3 | 2017 | 14331 | 0.10 | Why? |
| Metal Nanoparticles | 1 | 2017 | 771 | 0.10 | Why? |
| Proteomics | 1 | 2021 | 2481 | 0.10 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.10 | Why? |
| Animals | 12 | 2021 | 78931 | 0.10 | Why? |
| Killer Cells, Natural | 2 | 2021 | 2093 | 0.09 | Why? |
| Mice | 6 | 2019 | 21357 | 0.09 | Why? |
| Swine | 1 | 2017 | 3352 | 0.09 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.09 | Why? |
| Drug Discovery | 2 | 2018 | 3092 | 0.08 | Why? |
| Macrophages | 1 | 2018 | 2784 | 0.08 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2012 | 675 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| False Negative Reactions | 2 | 2021 | 1785 | 0.07 | Why? |
| SARS Virus | 2 | 2021 | 13021 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Biosensing Techniques | 1 | 2017 | 2116 | 0.06 | Why? |
| Aging | 1 | 2019 | 3581 | 0.06 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.06 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.06 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Mice, Inbred C57BL | 3 | 2018 | 5542 | 0.06 | Why? |
| Immobilized Proteins | 1 | 2021 | 47 | 0.06 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.06 | Why? |
| Matrix Metalloproteinase Inhibitors | 1 | 2021 | 45 | 0.06 | Why? |
| Mice, Transgenic | 2 | 2019 | 2739 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Virus Internalization | 2 | 2018 | 7921 | 0.05 | Why? |
| Angiography, Digital Subtraction | 1 | 2021 | 123 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Granzymes | 1 | 2021 | 197 | 0.05 | Why? |
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 8 | 0.05 | Why? |
| Time-Lapse Imaging | 1 | 2019 | 28 | 0.05 | Why? |
| Receptors, CCR7 | 1 | 2019 | 40 | 0.05 | Why? |
| Intravital Microscopy | 1 | 2019 | 34 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Mechanical Thrombolysis | 1 | 2021 | 150 | 0.05 | Why? |
| Chemokine CXCL12 | 1 | 2019 | 74 | 0.05 | Why? |
| Autophagy | 2 | 2021 | 960 | 0.05 | Why? |
| Ubiquitination | 1 | 2021 | 343 | 0.05 | Why? |
| Automation | 1 | 2021 | 429 | 0.05 | Why? |
| Cellular Microenvironment | 1 | 2018 | 55 | 0.05 | Why? |
| Transforming Growth Factor beta | 1 | 2021 | 363 | 0.05 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.05 | Why? |
| Blotting, Southern | 1 | 2017 | 18 | 0.04 | Why? |
| Butylated Hydroxyanisole | 1 | 2017 | 5 | 0.04 | Why? |
| Automation, Laboratory | 1 | 2021 | 536 | 0.04 | Why? |
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2018 | 108 | 0.04 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.04 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2017 | 40 | 0.04 | Why? |
| Antibodies, Monoclonal | 1 | 2017 | 8041 | 0.04 | Why? |
| Hepatitis B Core Antigens | 1 | 2017 | 76 | 0.04 | Why? |
| Protein Processing, Post-Translational | 1 | 2021 | 634 | 0.04 | Why? |
| Neoplastic Cells, Circulating | 1 | 2018 | 68 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Phosphorylation | 1 | 2021 | 1060 | 0.04 | Why? |
| Lab-On-A-Chip Devices | 1 | 2021 | 411 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2021 | 12361 | 0.04 | Why? |
| Infant | 1 | 2020 | 30274 | 0.04 | Why? |
| Astrocytes | 1 | 2019 | 298 | 0.04 | Why? |
| Sequence Homology | 1 | 2018 | 448 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Tissue Culture Techniques | 1 | 2017 | 158 | 0.04 | Why? |
| Prealbumin | 1 | 2018 | 203 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Immunoprecipitation | 1 | 2017 | 300 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Magnetite Nanoparticles | 1 | 2017 | 109 | 0.04 | Why? |
| Antigens | 1 | 2018 | 267 | 0.04 | Why? |
| Epigenomics | 1 | 2017 | 139 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2017 | 303 | 0.04 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Interleukin-17 | 1 | 2021 | 602 | 0.04 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.04 | Why? |
| Luminescent Measurements | 1 | 2021 | 924 | 0.04 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2017 | 264 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Blood-Brain Barrier | 1 | 2019 | 531 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| CHO Cells | 1 | 2017 | 831 | 0.04 | Why? |
| Blotting, Western | 1 | 2017 | 863 | 0.04 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Cricetulus | 1 | 2017 | 936 | 0.03 | Why? |
| Mutation | 3 | 2020 | 12376 | 0.03 | Why? |
| Cell Movement | 1 | 2018 | 695 | 0.03 | Why? |
| Datasets as Topic | 1 | 2021 | 1404 | 0.03 | Why? |
| Protein Interaction Maps | 1 | 2021 | 1333 | 0.03 | Why? |
| Autophagy-Related Protein 5 | 1 | 2012 | 28 | 0.03 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2021 | 1387 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Gold | 1 | 2017 | 592 | 0.03 | Why? |
| Alleles | 1 | 2019 | 1557 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
| Recombinant Fusion Proteins | 1 | 2017 | 919 | 0.03 | Why? |
| NF-kappa B | 1 | 2019 | 1301 | 0.03 | Why? |
| Disease Eradication | 1 | 2018 | 581 | 0.03 | Why? |
| Female | 7 | 2021 | 380317 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2020 | 1439 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2019 | 1074 | 0.03 | Why? |
| Gene Knockdown Techniques | 1 | 2012 | 347 | 0.03 | Why? |
| Microtubule-Associated Proteins | 1 | 2012 | 187 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2021 | 1585 | 0.03 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2012 | 249 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Interviews as Topic | 1 | 2020 | 1952 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2019 | 10998 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2021 | 2153 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Mitochondria | 1 | 2017 | 857 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.02 | Why? |
| Proteins | 1 | 2017 | 921 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.02 | Why? |
| Male | 5 | 2021 | 367725 | 0.02 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2021 | 3347 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Interferon-gamma | 1 | 2019 | 2711 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| RNA, Small Interfering | 1 | 2012 | 817 | 0.02 | Why? |
| Macaca mulatta | 1 | 2017 | 3716 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
| Feces | 1 | 2020 | 4235 | 0.02 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2019 | 3691 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.02 | Why? |
| Epitopes | 1 | 2017 | 4113 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Base Sequence | 1 | 2012 | 3581 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.01 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Travel | 1 | 2020 | 7220 | 0.01 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Protein Binding | 1 | 2017 | 11430 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Critical Care | 1 | 2021 | 14081 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Vero Cells | 1 | 2012 | 14117 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |